Literature DB >> 27519152

Method for single illumination source combined optical coherence tomography and fluorescence imaging of fluorescently labeled ocular structures in transgenic mice.

Ryan P McNabb1, Tomas Blanco2, Howard M Bomze2, Henry C Tseng2, Daniel R Saban2, Joseph A Izatt3, Anthony N Kuo2.   

Abstract

In vivo imaging permits longitudinal study of ocular disease processes in the same animal over time. Two different in vivo optical imaging modalities - optical coherence tomography (OCT) and fluorescence - provide important structural and cellular data respectively about disease processes. In this Methods in Eye Research article, we describe and demonstrate the combination of these two modalities producing a truly simultaneous OCT and fluorescence imaging system for imaging of fluorescently labeled animal models. This system uses only a single light source to illuminate both modalities, and both share the same field of view. This allows simultaneous acquisition of OCT and fluorescence images, and the benefits of both techniques are realized without incurring increased costs in variability, light exposure, time, and post-processing effort as would occur when the modalities are used separately. We then utilized this system to demonstrate multi-modal imaging in a progression of samples exhibiting both fluorescence and OCT scattering beginning with resolution targets, ex vivo thy1-YFP labeled neurons in mouse eyes, and finally an in vivo longitudinal time course of GFP labeled myeloid cells in a mouse model of ocular allergy.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Animal; Cornea; Fluorescence; GFP; OCT; Optical coherence tomography; Retina; YFP

Mesh:

Year:  2016        PMID: 27519152      PMCID: PMC5072542          DOI: 10.1016/j.exer.2016.08.003

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  21 in total

1.  Molecular contrast in optical coherence tomography by use of a pump-probe technique.

Authors:  K Divakar Rao; Michael A Choma; Siavash Yazdanfar; Andrew M Rollins; Joseph A Izatt
Journal:  Opt Lett       Date:  2003-03-01       Impact factor: 3.776

2.  Simultaneous optical coherence tomography and autofluorescence microscopy with a single light source.

Authors:  Cuixia Dai; Xiaojing Liu; Shuliang Jiao
Journal:  J Biomed Opt       Date:  2012-08       Impact factor: 3.170

3.  Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion.

Authors:  S Jung; J Aliberti; P Graemmel; M J Sunshine; G W Kreutzberg; A Sher; D R Littman
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

Review 4.  Optical coherence tomography: a new tool for glaucoma diagnosis.

Authors:  J S Schuman; M R Hee; A V Arya; T Pedut-Kloizman; C A Puliafito; J G Fujimoto; E A Swanson
Journal:  Curr Opin Ophthalmol       Date:  1995-04       Impact factor: 3.761

5.  The optics of human skin.

Authors:  R R Anderson; J A Parrish
Journal:  J Invest Dermatol       Date:  1981-07       Impact factor: 8.551

6.  Tri-modal microscopy with multiphoton and optical coherence microscopy/tomography for multi-scale and multi-contrast imaging.

Authors:  Shau Poh Chong; Tom Lai; Yifeng Zhou; Shuo Tang
Journal:  Biomed Opt Express       Date:  2013-08-08       Impact factor: 3.732

7.  In vivo imaging of murine retinal ganglion cells.

Authors:  Christopher K S Leung; James D Lindsey; Jonathan G Crowston; Won-Kyu Ju; Qwan Liu; Dirk-Uwe Bartsch; Robert N Weinreb
Journal:  J Neurosci Methods       Date:  2007-11-07       Impact factor: 2.390

8.  In vivo time-lapse fluorescence imaging of individual retinal ganglion cells in mice.

Authors:  Mark K Walsh; Harry A Quigley
Journal:  J Neurosci Methods       Date:  2007-12-08       Impact factor: 2.390

9.  Longitudinal in vivo imaging of retinal ganglion cells and retinal thickness changes following optic nerve injury in mice.

Authors:  Balwantray C Chauhan; Kelly T Stevens; Julie M Levesque; Andrea C Nuschke; Glen P Sharpe; Neil O'Leary; Michele L Archibald; Xu Wang
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

10.  Enhanced volumetric visualization for real time 4D intraoperative ophthalmic swept-source OCT.

Authors:  Christian Viehland; Brenton Keller; Oscar M Carrasco-Zevallos; Derek Nankivil; Liangbo Shen; Shwetha Mangalesh; Du Tran Viet; Anthony N Kuo; Cynthia A Toth; Joseph A Izatt
Journal:  Biomed Opt Express       Date:  2016-04-12       Impact factor: 3.732

View more
  4 in total

Review 1.  Transgenic models for investigating the nervous system: Currently available neurofluorescent reporters and potential neuronal markers.

Authors:  Michael Yamakawa; Samuel M Santosa; Neeraj Chawla; Evguenia Ivakhnitskaia; Matthew Del Pino; Sebastian Giakas; Arnold Nadel; Sneha Bontu; Arjun Tambe; Kai Guo; Kyu-Yeon Han; Maria Soledad Cortina; Charles Yu; Mark I Rosenblatt; Jin-Hong Chang; Dimitri T Azar
Journal:  Biochim Biophys Acta Gen Subj       Date:  2020-03-12       Impact factor: 3.770

2.  In Vivo Bioluminescence Imaging for Longitudinal Monitoring of Inflammation in Animal Models of Uveitis.

Authors:  Michal B Gutowski; Leslie Wilson; Russell N Van Gelder; Kathryn L Pepple
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-03-01       Impact factor: 4.799

3.  Revealing brain pathologies with multimodal visible light optical coherence microscopy and fluorescence imaging.

Authors:  Antonia Lichtenegger; Johanna Gesperger; Barbara Kiesel; Martina Muck; Pablo Eugui; Danielle J Harper; Matthias Salas; Marco Augustin; Conrad W Merkle; Christoph K Hitzenberger; Georg Widhalm; Adelheid Woehrer; Bernhard Baumann
Journal:  J Biomed Opt       Date:  2019-06       Impact factor: 3.170

4.  Spectroscopic imaging with spectral domain visible light optical coherence microscopy in Alzheimer's disease brain samples.

Authors:  Antonia Lichtenegger; Danielle J Harper; Marco Augustin; Pablo Eugui; Martina Muck; Johanna Gesperger; Christoph K Hitzenberger; Adelheid Woehrer; Bernhard Baumann
Journal:  Biomed Opt Express       Date:  2017-08-07       Impact factor: 3.732

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.